Metformin Xr Teva

Metformin Hydrochloride, the active ingredient in Metformin XR Teva, is a biguanide presented as an extended‑release tablet for oral use. It is employed to lower elevated blood glucose levels in adults with type 2 diabetes mellitus.

GNH USA supplies Metformin XR Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Our distribution network ensures timely delivery and reliable product integrity across diverse markets.

Metformin XR Teva is a biguanide indicated for the management of type 2 diabetes mellitus, a chronic disorder of glucose metabolism.

- Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose levels.

Metformin XR Teva may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic disturbance. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic failure: marked liver dysfunction. - Hypoglycemia: uncommon when used alone. - Vitamin B12 deficiency: may develop with long‑term use. - Pancreatitis: rare inflammation of the pancreas.

Metformin XR Teva requires careful consideration of patient‑specific factors and clinical monitoring.

- Renal function: avoid or adjust dose in patients with impaired renal clearance. - Hepatic impairment: use with caution in liver disease. - Lactic acidosis risk: discontinue if signs of metabolic acidosis appear. - Alcohol consumption: limit intake to reduce acidosis risk. - Contrast imaging: suspend therapy before iodinated contrast procedures. - Pregnancy category B: use only if clearly needed. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Metformin XR Teva can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and lactic acidosis. - Cimetidine: can increase metformin plasma concentrations. - Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: can affect renal function and metformin clearance. - ACE inhibitors/ARBs: monitor renal function and electrolytes. - Other antidiabetic agents: adjust dosing to avoid hypoglycemia. - Thyroid hormones: may require glucose monitoring.